  BOEHRINGER INGELHEIM For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4); and as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03. The duration of immunity against West Nile Virus is at least 12 months. DOSAGE AND ADMINISTRATION: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose. Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com |
|
 1 dose |
|
|
 6 x 1 dose @ 58.06 |
|
|
 10 dose @ 47.99/dose |
|
Please contact us for discount pricing on large orders. Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com | |||||||||||
